Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Helman

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
Current Oncology Reports|December 21, 2000
Targeting pediatric malignancies for T cell-mediated immune responsesC L Mackall, L J Helman
CA: a Cancer Journal for Clinicians|July 1, 1994
Pediatric soft tissue sarcomasL H Wexler, L J Helman
Advances in Experimental Medicine and Biology|January 1, 1993
IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesisC P Minniti, L J Helman
Critical Reviews in Oncogenesis|November 24, 2015
Preface: The Status of Pediatric Solid Tumors in 2015Carol J Thiele, Lee J Helman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
New strategies in ewing sarcoma: lost in translation?Fernanda I Arnaldez, Lee J Helman
Annales Pharmaceutiques Francaises|January 1, 1978
[Separation and analysis of belladonna leaf alkaloids in acid medium]A L De Dujovne, J Helman
Cancer Research|September 25, 2021
Recent Advances in Pediatric Cancer ResearchTroy A McEachron, Lee J Helman
Clinical Orthopaedics and Related Research|May 16, 2000
Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapyC Mackall, J Berzofsky, L J Helman
Cancer Research|November 1, 1994
In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2T Kalebic, M Tsokos, L J Helman
International Journal of Cancer|November 27, 1996
Suppression of rhabdomyosarcoma growth by fumagillin analog TNP-470T Kalebic, M Tsokos, L J Helman
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
Current Oncology Reports|December 21, 2000
Targeting pediatric malignancies for T cell-mediated immune responsesC L Mackall, L J Helman
CA: a Cancer Journal for Clinicians|July 1, 1994
Pediatric soft tissue sarcomasL H Wexler, L J Helman
Advances in Experimental Medicine and Biology|January 1, 1993
IGF-II in the pathogenesis of rhabdomyosarcoma: a prototype of IGFs involvement in human tumorigenesisC P Minniti, L J Helman
Critical Reviews in Oncogenesis|November 24, 2015
Preface: The Status of Pediatric Solid Tumors in 2015Carol J Thiele, Lee J Helman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
New strategies in ewing sarcoma: lost in translation?Fernanda I Arnaldez, Lee J Helman
Annales Pharmaceutiques Francaises|January 1, 1978
[Separation and analysis of belladonna leaf alkaloids in acid medium]A L De Dujovne, J Helman
Cancer Research|September 25, 2021
Recent Advances in Pediatric Cancer ResearchTroy A McEachron, Lee J Helman
Clinical Orthopaedics and Related Research|May 16, 2000
Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapyC Mackall, J Berzofsky, L J Helman
Cancer Research|November 1, 1994
In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2T Kalebic, M Tsokos, L J Helman
International Journal of Cancer|November 27, 1996
Suppression of rhabdomyosarcoma growth by fumagillin analog TNP-470T Kalebic, M Tsokos, L J Helman
Pageof 22